Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Pfizer May Have To Rethink Xalkori Cost Structure
Seeking Alpha
Sat, 03/30/13 - 11:02 am
Pfizer
Xalkori
lung cancer
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
lung cancer
Roche
Avastin
Tarceva
Astellas
Pfizer
Xalkori
Celgene
Abraxane
Gemzar
Alimta
Eli Lilly
Qiagen seeks FDA sign-off for lung cancer companion Dx
FierceMedicalDevice
Tue, 01/15/13 - 11:11 pm
Qiagen
FDA
lung cancer
regulatory
devices
Analysis: Alimta patent seen as Lilly's "wild card"
Yahoo/Reuters
Fri, 01/4/13 - 10:05 am
Alimta
Eli Lilly
lung cancer
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Germany's Merck suffers setback with cancer drug
Yahoo/AP
Wed, 12/19/12 - 11:46 am
Merck KGaA
lung cancer
Stimuvax
Is Big Pharma Utilizing Too Many Resources on Potential Blockbusters?
Forbes
Wed, 11/7/12 - 12:35 pm
Xalkori
lung cancer
Pfizer
Varian Medical Systems Highlights a Comprehensive Product Portfolio for the Non-Invasive Treatment of Lung Cancer
Wed, 10/31/12 - 10:55 pm
Varian Medical
treatment
lung cancer
cancer
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sun, 10/14/12 - 11:02 am
Celgene
NPS Pharmaceuticals
lung cancer
Abraxane
Gattex
short bowel syndrome
Celgene gets Abraxane nod
Yahoo/Investor's Business Daily
Sat, 10/13/12 - 12:05 pm
Celgene
Abraxane
lung cancer
Celgene Drug Abraxane OK'd For Lung Cancer; Shares Up
Investors.com
Fri, 10/12/12 - 11:31 am
Celgene
Abraxane
lung cancer
FDA
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer
Lilly releases Phase II results for monoclonal antibody ramucirumab
The Fly on the Wall
Mon, 10/1/12 - 10:25 am
Lilly
monoclonal antibodies
ramucirumab
lung cancer
Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say
Bloomberg
Sun, 09/30/12 - 10:36 am
Pfizer
Xalkori
lung cancer
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
Yahoo/PR Newswire
Sat, 09/29/12 - 12:25 pm
ramucirumab
lung cancer
Eli Lilly
Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Sat, 09/29/12 - 11:57 am
Nexavar
Bayer
lung cancer
Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup
TheStreet.com
Mon, 09/24/12 - 11:08 am
Peregrine Pharmaceuticals
lung cancer
bavituximab
Astex stops developing possible cancer treatment
Yahoo/AP
Fri, 09/21/12 - 12:03 pm
Astex
lung cancer
amuvatinib
Merck KGaA pulls second lung cancer drug filing
Reuters
Tue, 09/18/12 - 12:04 pm
Merck KGaA
lung cancer
Erbitux
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »